{"id":"https://openalex.org/W4283205041","doi":"https://doi.org/10.1016/j.vaccine.2022.06.032","title":"Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study","display_name":"Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study","publication_year":2022,"publication_date":"2022-06-20","ids":{"openalex":"https://openalex.org/W4283205041","doi":"https://doi.org/10.1016/j.vaccine.2022.06.032","pmid":"https://pubmed.ncbi.nlm.nih.gov/35738968","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9212435"},"language":"en","primary_location":{"id":"doi:10.1016/j.vaccine.2022.06.032","doi":"https://doi.org/10.1016/j.vaccine.2022.06.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2022.06.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X22007812/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0264410X22007812/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040053655","display_name":"Masaharu Shinkai","orcid":"https://orcid.org/0000-0002-4012-2518","observed_orcids":["https://orcid.org/0000-0002-4012-2518"]},"institutions":[{"id":"https://openalex.org/I4210157830","display_name":"Tokyo Shinagawa Hospital","ror":"https://ror.org/05y7zcx10","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210157830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaharu Shinkai","raw_affiliation_strings":["Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan","institution_ids":["https://openalex.org/I4210157830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079426665","display_name":"Takuhiro Sonoyama","orcid":"https://orcid.org/0009-0005-1734-8446","observed_orcids":["https://orcid.org/0009-0005-1734-8446"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuhiro Sonoyama","raw_affiliation_strings":["Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085735259","display_name":"Akari Kamitani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akari Kamitani","raw_affiliation_strings":["Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065215228","display_name":"Risa Yokokawa Shibata","orcid":"https://orcid.org/0000-0002-5276-4358","observed_orcids":["https://orcid.org/0000-0002-5276-4358"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Risa Yokokawa Shibata","raw_affiliation_strings":["Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046022569","display_name":"Naomi M. Seki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naomi M. Seki","raw_affiliation_strings":["Shionogi & Co., Ltd., Pharmaceutical Research Division, 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Pharmaceutical Research Division, 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023149228","display_name":"Shinya Omoto","orcid":"https://orcid.org/0000-0002-2730-3912","observed_orcids":["https://orcid.org/0000-0002-2730-3912"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinya Omoto","raw_affiliation_strings":["Shionogi & Co., Ltd., Pharmaceutical Research Division, 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Pharmaceutical Research Division, 1-1, Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040492584","display_name":"Masahiro Shinoda","orcid":"https://orcid.org/0000-0002-0288-5637","observed_orcids":["https://orcid.org/0000-0002-0288-5637"]},"institutions":[{"id":"https://openalex.org/I4210157830","display_name":"Tokyo Shinagawa Hospital","ror":"https://ror.org/05y7zcx10","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210157830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Shinoda","raw_affiliation_strings":["Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan","institution_ids":["https://openalex.org/I4210157830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086694128","display_name":"Takashi Sato","orcid":"https://orcid.org/0000-0002-2676-3781","observed_orcids":["https://orcid.org/0000-0002-2676-3781"]},"institutions":[{"id":"https://openalex.org/I4210157830","display_name":"Tokyo Shinagawa Hospital","ror":"https://ror.org/05y7zcx10","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210157830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Sato","raw_affiliation_strings":["Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan","institution_ids":["https://openalex.org/I4210157830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080943867","display_name":"Naoki Ishii","orcid":"https://orcid.org/0000-0003-4876-1063","observed_orcids":["https://orcid.org/0000-0003-4876-1063"]},"institutions":[{"id":"https://openalex.org/I4210157830","display_name":"Tokyo Shinagawa Hospital","ror":"https://ror.org/05y7zcx10","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210157830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Ishii","raw_affiliation_strings":["Department of Gastroenterology, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Tokyo Shinagawa Hospital, 6-3-22 Higashioi, Shinagawa-ku, Tokyo 140-8522, Japan","institution_ids":["https://openalex.org/I4210157830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102191097","display_name":"Kenji Igarashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Igarashi","raw_affiliation_strings":["Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076075780","display_name":"Mari Ariyasu","orcid":"https://orcid.org/0000-0002-5109-9448","observed_orcids":["https://orcid.org/0000-0002-5109-9448"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mari Ariyasu","raw_affiliation_strings":["Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan. Electronic address: mari.tatsuno@shionogi.co.jp","Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan. Electronic address: mari.tatsuno@shionogi.co.jp","institution_ids":["https://openalex.org/I4210118477"]},{"raw_affiliation_string":"Shionogi & Co., Ltd., Drug Development and Regulatory Science Division, 8F, Nissay Yodoyabashi East Bldg., 3-3-13, Imabashi, Chuo-ku, Osaka 541-0042, Japan","institution_ids":["https://openalex.org/I4210118477"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076075780"],"corresponding_institution_ids":["https://openalex.org/I4210118477"],"apc_list":{"value":3350,"currency":"USD","value_usd":3350},"apc_paid":{"value":3350,"currency":"USD","value_usd":3350},"fwci":2.1585,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.89104655,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"40","issue":"32","first_page":"4328","last_page":"4333"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bnt162b2","display_name":"BNT162b2","score":0.8140000104904175},{"id":"https://openalex.org/keywords/covid-19-vaccine-booster","display_name":"COVID-19 booster vaccination","score":0.9279999732971191},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.9259999990463257},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9629999995231628},{"id":"https://openalex.org/keywords/seroresponse","display_name":"seroresponse","score":0.8119999766349792},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.828000009059906},{"id":"https://openalex.org/keywords/omicron-variant","display_name":"Omicron variant","score":0.8389999866485596},{"id":"https://openalex.org/keywords/delta-variant","display_name":"Delta variant","score":0.996999979019165},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.8539999723434448},{"id":"https://openalex.org/keywords/reactogenicity","display_name":"reactogenicity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/japanese-adults","display_name":"Japanese adults","score":0.902999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8150509595870972},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7125487327575684},{"id":"https://openalex.org/C2777704310","wikidata":"https://www.wikidata.org/wiki/Q7300322","display_name":"Reactogenicity","level":4,"score":0.7005220055580139},{"id":"https://openalex.org/C203165030","wikidata":"https://www.wikidata.org/wiki/Q741745","display_name":"Booster (rocketry)","level":2,"score":0.5485728979110718},{"id":"https://openalex.org/C12590561","wikidata":"https://www.wikidata.org/wiki/Q2920497","display_name":"Booster dose","level":4,"score":0.4959498345851898},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.4814411997795105},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4151148796081543},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.38119640946388245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3756566047668457},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27593937516212463},{"id":"https://openalex.org/C1276947","wikidata":"https://www.wikidata.org/wiki/Q333","display_name":"Astronomy","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000071497","descriptor_name":"Immunogenicity, Vaccine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000090982","descriptor_name":"BNT162 Vaccine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.vaccine.2022.06.032","doi":"https://doi.org/10.1016/j.vaccine.2022.06.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2022.06.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X22007812/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},{"id":"doi:10.1101/2022.03.03.22271827","doi":"https://doi.org/10.1101/2022.03.03.22271827","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2022.03.03.22271827","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2022/04/01/2022.03.03.22271827.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},{"id":"pmid:35738968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35738968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:9212435","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9212435/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.vaccine.2022.06.032","doi":"https://doi.org/10.1016/j.vaccine.2022.06.032","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vaccine.2022.06.032","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0264410X22007812/pdf","source":{"id":"https://openalex.org/S27359860","display_name":"Vaccine","issn_l":"0264-410X","issn":["0264-410X","1873-2518"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vaccine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G600875627","display_name":null,"funder_award_id":"JP21nf010626","funder_id":"https://openalex.org/F4320323374","funder_display_name":"Universit\u00e0 degli Studi del Piemonte Orientale"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320317472","display_name":"Tokyo Shinagawa Hospital","ror":"https://ror.org/05y7zcx10"},{"id":"https://openalex.org/F4320321945","display_name":"Ministry of Health, Labour and Welfare","ror":"https://ror.org/03mwa7s65"},{"id":"https://openalex.org/F4320323316","display_name":"Shionogi","ror":"https://ror.org/01v3bqg10"},{"id":"https://openalex.org/F4320323374","display_name":"Universit\u00e0 degli Studi del Piemonte Orientale","ror":"https://ror.org/04387x656"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283205041.pdf","grobid_xml":"https://content.openalex.org/works/W4283205041.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W3137566438","https://openalex.org/W3198390285","https://openalex.org/W3200511289","https://openalex.org/W3200674187","https://openalex.org/W3202826390","https://openalex.org/W3203611764","https://openalex.org/W3210126657","https://openalex.org/W3212447088","https://openalex.org/W3215964500","https://openalex.org/W3217262401","https://openalex.org/W4205283268","https://openalex.org/W4206040938","https://openalex.org/W4206774638","https://openalex.org/W4210792795","https://openalex.org/W4225386205","https://openalex.org/W4225982774","https://openalex.org/W4280615609","https://openalex.org/W4290987220"],"related_works":["https://openalex.org/W4386827121","https://openalex.org/W7167231275","https://openalex.org/W4396219379","https://openalex.org/W4313550246","https://openalex.org/W4280615609","https://openalex.org/W4410208860","https://openalex.org/W4400015532","https://openalex.org/W4281743781","https://openalex.org/W4396988451","https://openalex.org/W6958469514"],"abstract_inverted_index":{"Abstract":[0],"In":[1,134],"this":[2],"randomized,":[3],"observer-blinded,":[4],"phase":[5,166],"2/3":[6,167],"study,":[7],"S-268019-b":[8,45,136,181,201],"(n=101),":[9],"a":[10,25,144,210],"recombinant":[11],"spike":[12],"protein":[13],"vaccine,":[14],"was":[15,137,182,202],"analyzed":[16],"for":[17,51,169],"noninferiority":[18,43,70,79],"versus":[19,46,62],"tozinameran":[20,31,47,185],"(n=103),":[21],"when":[22],"given":[23],"as":[24,143,149,209],"booster":[26,151,170,211],"\u22656":[27,171],"months":[28,172],"after":[29,173],"2-dose":[30],"regimen":[32],"in":[33,48,108,177,186,212],"Japanese":[34],"adults":[35,214],"without":[36],"prior":[37],"COVID-19":[38,150,158],"infection.":[39],"Interim":[40,165],"results":[41,205],"showed":[42,140],"of":[44],"co-primary":[49],"endpoints":[50],"neutralizing":[52,96,188],"antibodies":[53,97,189],"on":[54,115],"day":[55],"29:":[56],"geometric":[57],"mean":[58],"titer":[59],"(GMT)":[60],"(124.97":[61],"109.70;":[63],"adjusted-GMT":[64],"ratio":[65],"[95%":[66],"CI],":[67],"1.14":[68],"[0.94-1.39];":[69],"P":[71,80],"-value,":[72,81],"<0.0001)":[73],"and":[74,90,95,100,103,125,139,197,204],"seroresponse":[75],"rate":[76],"(both":[77],"100%;":[78],"0.0004).":[82],"Both":[83],"vaccines":[84,194],"elicited":[85],"anti-spike-protein":[86],"immunoglobulin":[87],"G":[88],"antibodies,":[89],"produced":[91],"T-cell":[92],"response":[93,164],"(n=29/group)":[94],"against":[98],"Delta":[99,196],"Omicron":[101,198],"pseudovirus":[102],"live":[104],"virus":[105,199],"variants":[106,200],"(n=24/group)":[107],"subgroups.":[109],"Most":[110],"participants":[111],"reported":[112],"low-grade":[113],"reactogenicity":[114],"days":[116],"1-2,":[117],"the":[118,174],"most":[119],"frequent":[120],"being":[121],"fatigue,":[122],"fever,":[123],"myalgia,":[124],"injection-site":[126],"pain.":[127],"No":[128],"serious":[129],"adverse":[130],"events":[131],"were":[132],"reported.":[133],"conclusion,":[135],"safe":[138],"robust":[141],"immunogenicity":[142],"booster,":[145],"supporting":[146],"its":[147,207],"use":[148,208],"vaccine.":[152],"JRCT":[153],"ID":[154],"jRCT2031210470":[155],"Highlights":[156],"Third":[157],"vaccine":[159],"dose":[160,176],"(booster)":[161],"enhances":[162],"immune":[163],"data":[168],"2nd":[175],"Japan":[178],"are":[179],"shown":[180],"noninferior":[183],"to":[184],"inducing":[187],"Sera":[190],"boosted":[191],"with":[192],"either":[193],"neutralized":[195],"safe,":[203],"support":[206],"vaccinated":[213]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-06-22T00:00:00"}